ABEONA THERAPEUTICS INC. Earnings Per Share, Basic and Diluted
ABEONA THERAPEUTICS INC. (ABEO) reported Earnings Per Share, Basic and Diluted of -$0.86 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-31
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.44.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.07.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.16.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.17.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2021 was -$0.86.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2020 was -$0.91.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2019 was -$1.51.
- ABEONA THERAPEUTICS INC. earnings per share, basic and diluted for fiscal 2018 was -$1.19.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.86 10-K · filed 2022-03-31 | |||
| 2021-09-30 | -$0.07 10-Q · filed 2021-11-15 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.40 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | -$0.16 10-Q · filed 2021-07-28 | -$0.33 10-Q · filed 2021-07-28 | |||||
| 2021-03-31 | -$0.17 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | -$0.91 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-15 | -$0.74 10-Q · filed 2021-11-15 | -$0.73 10-Q · filed 2020-11-09 | ||||
| 2020-06-30 | -$0.14 10-Q · filed 2021-07-28 | -$0.66 10-Q · filed 2021-07-28 | |||||
| 2020-03-31 | -$0.52 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | -$0.30 10-K · filed 2020-03-16 | -$1.51 10-K · filed 2021-03-24 | |||||
| 2019-09-30 | -$0.35 10-Q · filed 2020-11-09 | -$1.22 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | -$0.49 10-Q · filed 2020-08-10 | -$0.88 10-Q · filed 2020-08-10 | |||||
| 2019-03-31 | -$0.39 10-Q · filed 2020-05-06 | ||||||
| 2018-12-31 | -$0.36 10-K · filed 2020-03-16 | -$1.19 10-K · filed 2020-03-16 | |||||
| 2018-09-30 | -$0.34 10-K · filed 2020-03-16 | -$0.83 10-Q · filed 2019-11-12 | -$0.77 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | -$0.26 10-K · filed 2020-03-16 | -$0.25 10-Q · filed 2018-08-09 | -$0.48 10-Q · filed 2019-08-09 | -$0.43 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | -$0.22 10-K · filed 2020-03-16 | -$0.18 10-Q · filed 2018-05-10 | |||||
| 2017-12-31 | -$0.19 10-K · filed 2019-03-18 | -$0.66 10-K · filed 2020-03-16 | |||||
| 2017-09-30 | -$0.13 10-K · filed 2019-03-18 | -$0.47 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | -$0.21 10-K · filed 2019-03-18 | -$0.34 10-Q · filed 2018-08-09 | |||||
| 2017-03-31 | -$0.13 10-K · filed 2019-03-18 | ||||||
| 2016-12-31 | -$0.64 10-K · filed 2019-03-18 | ||||||
| 2016-09-30 | -$0.08 10-Q · filed 2017-11-14 | -$0.45 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | -$0.20 10-Q · filed 2017-08-14 | -$0.37 10-Q · filed 2017-08-14 | |||||
| 2016-03-31 | -$0.17 10-Q · filed 2017-05-15 | ||||||
| 2015-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2017-03-30 | -$0.26 derived: net income ÷ weighted average shares · filed 2017-03-30 | -$0.42 derived: net income ÷ weighted average shares · filed 2017-03-30 | -$0.53 10-K · filed 2017-03-30 | |||
| 2015-09-30 | -$0.19 10-Q · filed 2016-11-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$0.47 10-Q · filed 2016-11-14 | -$1.19 derived: net income ÷ weighted average shares · filed 2016-11-14 | |||
| 2015-06-30 | -$0.16 10-Q · filed 2016-08-15 | -$0.27 10-Q · filed 2016-08-15 | -$1.08 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$1.60 derived: net income ÷ weighted average shares · filed 2016-08-15 | |||
| 2015-03-31 | -$0.10 10-Q · filed 2016-05-16 | -$1.12 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$1.89 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$4.42 derived: net income ÷ weighted average shares · filed 2016-05-16 | |||
| 2014-12-31 | -$2.04 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$4.41 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$11.61 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$15.26 10-K · filed 2016-03-30 | |||
| 2014-09-30 | -$4.15 10-Q · filed 2015-11-16 | -$29.24 derived: net income ÷ weighted average shares · filed 2015-11-16 | -$32.46 10-Q · filed 2015-11-16 | ||||
| 2014-06-30 | -$25.26 10-Q · filed 2015-08-14 | -$28.46 10-Q · filed 2015-08-14 | |||||
| 2014-03-31 | -$3.06 10-Q · filed 2015-05-14 | ||||||
| 2012-12-31 | $0.79 derived: net income ÷ weighted average shares · filed 2014-03-26 | $0.16 derived: net income ÷ weighted average shares · filed 2014-03-26 | -$0.30 derived: net income ÷ weighted average shares · filed 2014-03-26 | -$0.52 10-K · filed 2013-03-20 | |||
| 2012-09-30 | -$0.63 10-Q · filed 2012-11-14 | -$1.09 derived: net income ÷ weighted average shares · filed 2013-11-14 | -$1.31 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | -$0.46 10-Q · filed 2012-08-14 | -$0.68 10-Q · filed 2012-08-14 | |||||
| 2011-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2013-03-20 | -$0.01 derived: net income ÷ weighted average shares · filed 2013-03-20 | -$0.10 derived: net income ÷ weighted average shares · filed 2013-03-20 | -$0.22 10-K · filed 2013-03-20 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2012-11-14 | -$0.21 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | -$0.09 10-Q · filed 2012-08-14 | -$0.21 10-Q · filed 2012-08-14 | |||||
| 2010-12-31 | -$0.60 10-K · filed 2012-03-23 | ||||||
| 2010-09-30 | -$0.83 10-Q · filed 2011-11-14 | -$0.73 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |